Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells.
about
Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNALong non-coding RNAs in anti-cancer drug resistanceProtein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell linesInsights from Global Analyses of Long Noncoding RNAs in Breast CancerMeta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways.Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) Drives Proliferation of IPH-926 lobular Carcinoma Cells.Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNAMicroarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancerBCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinibLong noncoding RNAs in cancer: from function to translation.LncRNADisease: a database for long-non-coding RNA-associated diseases.The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progressionDysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication.Long noncoding RNAs in liver cancer: what we know in 2014.Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies.Long noncoding RNAs in lung cancer: what we know in 2015.Long non-coding RNA BCAR4 promotes chondrosarcoma cell proliferation and migration through activation of mTOR signaling pathway.From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis.The Regulatory Role of Long Noncoding RNAs in Cancer Drug Resistance.Long Non-coding RNAs and their Role in Metastasis.Noncoding RNAs in Therapeutic Resistance of Cancer.lncRNA directs cooperative epigenetic regulation downstream of chemokine signalsLong non-coding RNAs as novel biomarkers for breast cancer invasion and metastasisGlobal network random walk for predicting potential human lncRNA-disease associations.LncRNA BCAR4 promotes colon cancer progression via activating Wnt/β-catenin signaling.LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism.Breast-cancer anti-estrogen resistance 4 (BCAR4) encodes a novel maternal-effect protein in bovine and is expressed in the oocyte of humans and other non-rodent mammals.Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.LncRNA XIST promotes human lung adenocarcinoma cells to cisplatin resistance via let-7i/BAG-1 axis.Deciphering the roles of lncRNAs in breast development and disease.Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.Research progresses in roles of LncRNA and its relationships with breast cancer
P2860
Q27011221-080A2F17-E024-43D2-9B36-08B561B5EA1AQ28072366-39F3986F-168A-4CAD-BC7E-159A071F22E1Q28259553-3D5577A0-40A6-418B-B046-41EA7C6238ABQ33787422-D74888A0-4DE2-4902-B7B6-894609733EEFQ34248904-419AFCBA-9BDC-470D-AC29-6461EC840996Q35758871-F17BCA1A-FDAD-440C-A9B7-4079F9A3EA57Q35961138-9705DE00-FE1B-4AD9-A3F7-FAA73F83B17BQ36213198-E60F4B2A-C9AF-42CF-AEC8-FEF442D520CBQ36299102-B3CAE2ED-F04B-4052-A57C-71BB67516C29Q36353705-12E639E1-1CB0-4E05-AE4D-EAFA3B02BB7EQ36491482-06DEB93C-C492-4FDD-843E-9FCA8768FF42Q37315073-C400C357-E064-46E2-9F8B-5E16E6E258A7Q37706387-1DABC03E-E269-426C-92B2-16B27CC3BA68Q38241983-D9E1CE77-5585-436F-8CD0-8F402B2ABA8DQ38639536-CF19E0A9-4F64-439D-BB67-F90E54DBEBB5Q38672942-2829AB55-3A2B-46B4-BDA4-0D2769A2BFB2Q38708065-08334D36-F576-4D79-8D91-059757ABE6DFQ38732993-BB9200A5-8512-42A7-B36B-15A6A53BA3F4Q38748127-2212F7A7-3CC5-40A7-A5B6-B44A7A7BD92CQ38818070-7B2CE0C2-0953-487F-9FF8-2CE40C055FBDQ38885495-CBE16075-2E05-4B54-AA1A-01E79BC4448DQ38938483-A25EC129-0E8C-4319-B2A6-66C024B2461DQ41143566-881B9385-C994-434E-B00C-0A141BD53610Q42367781-049737A1-BC3D-48B9-BB61-2A4298442A8AQ45771313-D2770147-5133-4A91-8FD9-E5664B58CB10Q46087828-AD1AC6C9-C5DD-4B7C-AA42-F16C2C03370CQ48635126-0792ADE3-1EB9-47F9-9BB4-45F12D8A0539Q51615433-75828562-902D-4093-917D-42E4245995CDQ52753259-72BE8A8A-22F9-43ED-B320-B47C22A1BE22Q54975879-DFE42770-9299-4B56-BDFA-90C33089AB28Q55438036-1B681A9C-2E4D-4417-A18A-B6884C236D1DQ59136248-200F36CF-A6ED-430D-A125-271C873574B9
P2860
Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Characterization of BCAR4, a n ...... in human breast cancer cells.
@en
Characterization of BCAR4, a n ...... in human breast cancer cells.
@nl
type
label
Characterization of BCAR4, a n ...... in human breast cancer cells.
@en
Characterization of BCAR4, a n ...... in human breast cancer cells.
@nl
prefLabel
Characterization of BCAR4, a n ...... in human breast cancer cells.
@en
Characterization of BCAR4, a n ...... in human breast cancer cells.
@nl
P2093
P2860
P356
P1476
Characterization of BCAR4, a n ...... in human breast cancer cells.
@en
P2093
Buddy Setyono-Han
Danielle Meijer
Lambert C J Dorssers
Marcia Godinho
Ton van Agthoven
P2860
P304
P356
10.1002/JCP.22503
P577
2011-07-01T00:00:00Z